United States Gears Up Against Bird Flu with $72M Vaccine Investment

The U. S. government has decided to invest $72 million to prepare bird flu vaccines, ensuring they are ready if needed. This investment, made by the Department of Health & Human Services (HHS), is a precautionary measure. The money will go to CSL Seqirus, Sanofi, and GSK. These pharmaceutical companies will use the funds to fill and finish vaccines, making sure they are ready for distribution. The process involves transferring vaccines from bulk storage into vials or pre-filled syringes. This step ensures the vaccines are immediately usable. David Boucher, from HHS' Administration for Strategic Preparedness and Response (ASPR), explained that this action will boost the country's readiness against new types of influenza, including the H5 strain. In addition to the current vaccines, these companies will also produce more influenza antigen. This is the part of the vaccine that prompts an immune response. The goal is to create antigens that match the bird flu strains currently circulating. Previously, health officials had prepared nearly 5 million vaccine doses. With the new funding, they anticipate doubling this stockpile to over 10 million doses by the first quarter of 2025. Other companies like Pfizer and Moderna are working on developing mRNA vaccines specifically for bird flu. This technology is similar to that used in their COVID-19 vaccines. So far, there have been 16 cases of bird flu in the U. S. this year. The general public's risk is low, according to the CDC. However, those who work with potentially infected livestock should take appropriate safety measures. Dawn O'Connell, an assistant secretary at HHS, emphasized that this funding ensures the country has additional pandemic influenza vaccines available if needed. Sanofi is also preparing to manufacture an egg-based influenza vaccine, like one for H5 influenza, if the need arises. The HHS is taking these steps to increase vaccine availability, just in case the risk of human infection rises.